CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- S-1 Offering Registration Statement
- S-1 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Material agreement · Unregistered share sale
- 4 Open-market buy Director bought 5,000 shares at $6.00 ($30,000)
- 8-K Event Material agreement · Unregistered share sale
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- 4 Grant or award Director acquired 32,000 shares (grant or award)
- 4 Grant or award Director acquired 32,000 shares (grant or award)
- 4 Other acquisition 10% owner acquired 20,000 shares (other)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 20,000 shares (grant or award)
Page 29 of 63 · 1,250 filings